Quantinental Pharmachem Profile
Key Indicators
- Authorised Capital ₹ 4.50 M
- Paid Up Capital ₹ 4.50 M
- Company Age 7 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.98 Cr
- Revenue Growth 115.10%
- Profit Growth 31.78%
- Ebitda 1209.00%
- Net Worth -137.48%
- Total Assets -8.14%
About Quantinental Pharmachem
Quantinental Pharmachem Private Limited (QPPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 03 April 2017 (Seven years and nine months 30 days old ). Its registered office is in Aurangabad, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.50 M and a paid-up capital of Rs 4.50 M.
The company currently has active open charges totaling ₹1.98 Cr.
Babasaheb Nikam, Mahesh Thube, Manisha Thube, and One other member serve as directors at the Company.
Company Details
-
Location
Aurangabad, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74999MH2017PTC293324
-
Company No.
293324
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
03 Apr 2017
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Quantinental Pharmachem?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mahesh Thube
|
Director | 15-Nov-2018 | Current |
|
Babasaheb Nikam
|
Director | 22-Mar-2021 | Current |
|
Manisha Thube
|
Director | 03-Apr-2017 | Current |
|
Varsha Padalkar
|
Director | 03-Apr-2017 | Current |
Financial Performance of Quantinental Pharmachem.
Quantinental Pharmachem Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 115.1% increase. The company also saw a substantial improvement in profitability, with a 31.78% increase in profit. The company's net worth observed a substantial decline by a decrease of 137.48%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Quantinental Pharmachem?
In 2023, Quantinental Pharmachem had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Waterwaves Industries Private LimitedBabasaheb Nikam is a mutual person
-
Shri Gurudeodatta Technocrate Private Limited
Babasaheb Nikam is a mutual person
Charges (Loans)
₹19.80 M
₹0
Charges Breakdown by Lending Institutions
- Canara Bank : 1.98 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Feb 2020 | Canara Bank | ₹1.98 Cr | Open |
How Many Employees Work at Quantinental Pharmachem?
Unlock and access historical data on people associated with Quantinental Pharmachem, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Quantinental Pharmachem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Quantinental Pharmachem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
